The use of fluorescent intrabodies to detect endogenous gankyrin in living cancer cells

Experimental Cell Research

Volumn 319, Issue 6, 2013, Pages 838-849

  Rinaldi, Anne Sophie ^a,b   Freund, Guillaume ^a   Desplancq, Dominique ^a   Sibler, Annie Paule ^a   Baltzinger, Mireille ^a   Rochel, Natacha ^a   Mély, Yves ^a   Didier, Pascal ^a   Weiss, Etienne ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

FLIM FRET; Gankyrin; Imaging in living cells; Intrabodies; Intracellular targeting; Single chain Fv

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GANKYRIN; GANKYRIN ANTIBODY; HYBRID PROTEIN; ONCOPROTEIN; PROTEIN ANTIBODY; RED FLUORESCENT PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY STRUCTURE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS; CELL TRANSPORT; CONTROLLED STUDY; CYTOPLASM; FEMALE; FLUORESCENCE ANALYSIS; FLUORESCENCE LIFETIME IMAGING MICROSCOPY; GEL FILTRATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; INTRACELLULAR TRANSPORT; MICROSCOPY; PRIORITY JOURNAL; PROTEIN DETERMINATION; RNA INTERFERENCE;

MAMMALIA;

EID: 84875239714     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.01.011     Document Type: Article

References (53)

1. Ibraheem A., Campbell R.E. Designs and applications of fluorescent protein-based biosensors. Curr. Opin. Chem. Biol. 2010, 14:30-36.
2. Ellenberg J., Lippincott-Schwartz J. Dynamics and mobility of nuclear envelope proteins in interphase and mitotic cells revealed by green fluorescent protein chimeras. Methods 1999, 19:362-372.
3. Voss T.C., Demarco I.A., Day R.N. Quantitative imaging of protein interactions in the cell nucleus. Biotechniques 2005, 38:413-434.
4. Ramdzan Y.M., Polling S., Chia C., Ng I.H.W., Ormsby A.R., Croft N.P., Purcell A.W., Bogoyevitch M.A., Ng D.C.H., Gleeson P.A., hatters D.M. Tracking protein aggregation and mislocalization in cells with flow cytometry. Nat. Methods 2012, 9:467-470.
5. Marschall A.L., Frenzel A., Schirrmann T., Schüngel M., Dübel S. Targeting antibodies to the cytoplasm. MAbs 2011, 3-16.
6. Rothbauer U., Zolghadr K., Tillib S., Nowak D., Shermelleh L., Gahl A., Backman N., Conrath K., Muyldermans S., Cardoso M.C., Leonhardt H. Targeting and tracing antigens in live cells with fluorescent nanobodies. Nat. Methods 2006, 3:887-889.
7. Vercruysse T., Pardon E., Vanstreels E., Steyaert J., Daelemans D. An intrabody based on a llama single-domain antibody targeting the N-terminal alpha-helical multimerization domain of HIV-1 rev prevents viral production. J. Biol. Chem. 2010, 285:21768-21780.
8. J.M. Lecerf, T.L. Shirley, Q. Zhu, A. Kasantsev, P. Amersdorfer, D.E. housman, A. Messer, J.S. Houston, Human single-chain Fv intrabodies counteract in situ hungtingtin aggregation in cellular models of Huntington's disease, Proc. Nat. Acad. Sci. U.S.A. 98 (200&) 4764-4769.
9. Cardinale A., Filesi I., Mattei S., Biocca S. Intracellular targeting and functional analysis of single-chain Fv fragments in mammalian cells. Methods 2004, 34:171-178.
10. Tanaka T., Rabbitts T.H. Functional intracellular antibody fragments do not require invariant intra-domain disulfide bridges. J. Mol. Biol. 2008, 376:749-757.
11. Zacchi P., Dreosti E., Visintin M., Moretto-Zita M., Marchionni I., Cannistraci I., Kazap Z., Betz H., Cattaneo A., Cherubini E. Gephyrin selective intrabodies as a new strategy for studying inhibitory eceptor clustering. J. Mol. Neurosci. 2008, 34:141-148.
12. Accardi L., Di Bonito P. Antibodies in single-chain format against tumour-associated antigens: present and future applications. Curr. Med. Chem. 2010, 17:1730-1755.
13. Butler D.C., Messer A. Bifunctional anti-huntingtin proteasome-directed intrabodies mediate efficient degradation of mutant huntingtin exon 1 protein fragments. PLos One 2012, 6:e29199.
14. Nizak C., Martin-Lluesma S., Moutel S., Roux A., Kreis T.E., Goud B., Perez F. Recombinant antibodies against subcellular fractions used to track endogenous golgi protein dynamics in vivo. Traffic 2003, 4:739-753.
15. Sibler A.P., Courtĉte J., Muller C.D., Zeder-Lutz G., Weiss E. Extended half-life upon binding of destabilized intrabodies allows specific detection of antigen in mammalian cells. FEBS J 2005, 272:2878-2891.
16. Kvam E., Sierks M.R., Shoemaker C.B., Messer A. Physico-chemical detrminants of soluble intrabody expression in mammalian cell cytoplasm. Protein Eng. Des. Sel. 2010, 2:489-498.
17. Ries J., Kaplan C., Platonova E., Eghlidi H., Ewers H. A simple, versatile method for GFP-based super-resolution microscopy via nanobodies. Nat. Methods 2012, 9:582-584.
18. Desplancq D., Rinaldi A.S., Stoessel A., Sibler A.P., Busso D., Oulad-Abdelghani M., van Regenmortel M.H., Weiss E. Single-chain Fv fragment antibodies selected from an intrabody library as effective mono- or bivalent reagents for in vitro protein detection. J. Immunol. Methods 2011, 369:42-50.
19. Higashitsuji H., Higashitsuji H., Liu Y., Masuda T., Fujita T., Abdel-Aziz H.I., kongkham S., Dawson S., Mayer R.J., Itoh Y., Sakurai T., Itoh K., Fujita J. The oncoprotein gankyrin interacts with RelA and suppresses NF-kB activity. Biochem. Biophys. Res. Commun 2007, 363:879-884.
20. Chen Y., Li H.H., Wang X.F., Ren Y.B., Dong L.W., Tang S.H., Liu S.Q., Wu M.C., Wang H.Y. Oncoprotein p28GANK binds to RelA and retains NF-kB in the cytoplasm trough nuclear export. Cell Res. 2007, 17:1020-1029.
21. Iakova P., Timchenko L., Timchenko N.A. Intracellular signaling and hepatocellular carcinoma. Semin. Cancer Biol. 2011, 21:28-34.
22. Krzywda S., Brzozowski A.M., Higashitsuji H., Fujita J., Welchman R., Dawson S., Mayer R.J., Wilkinson A.J. The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19S proteosomal regulator, and the tumor suppressors Rb and p53. J. Biol. Chem. 2004, 279:1541-1545.
23. Padmanabhan B., Adachi N., Kataoka K., Horikoshi M. Crystal structure of the homolog of the oncoprotein gankyrin, an interactor of Rb and CDK4/6. J. Biol. Chem 2004, 279:1546-1552.
24. Weibrecht I., Leuchowius K.J., Clausson C.M., Conze T., Jarvius M., Howell W.M., Kamali-Moghaddam M., Söderberg O. Proximity ligation assays: a recent addition to the proteomics toolbox. Expert Rev. Proteomics 2010, 7:401-409.
25. Truong K., Ikura M. The use of FRET imaging microscopy to detect protein-protein interactions and protein conformational changes in vivo. Curr. Opin. Struct. Biol. 2001, 11:573-578.
26. Wallrabe H., Periasamy A. Imaging protein molecules using FRET and FLIM microscopy. Curr. Opin. Biotechnol. 2005, 16:19-27.
27. Sun Y., Day R.N., Periasamy A. Investigating protein-protein interactions in living cells using fluorescence lifetime imaging microscopy. Nat. Protocols 2011, 6:1324-1340.
28. Padilla-Parra S., Tramier M. FRET microscopy in the living cell: different approaches, strengths and weaknesses. Bioessays 2012, 34:369-376.
29. Philibert P., Stoessel A., Wang W., Sibler A.P., Bec N., Larroque C., Saven J.G., Courtĉte J., Weiss E., Martineau P. A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm. BMC Biotechnol. 2007, 7:81.
30. Evan G.I., Lewis G.K., Ramsay G., Bishop J.M. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 1985, 5:3610-3615.
31. Courtĉte J., Sibler A.P., Zeder-Lutz G., Dalkara D., Oulad-Abdelghani M., Zuber G., Weiss E. Suppression of cervical carcinoma cell growth by intracytoplasmic codelivery of anti-oncoprotein E6 antibody and small interfering RNA. Mol. Cancer Ther. 2007, 6. 1728-35.
32. Fritz J.V., Didier P., Clamme J.-P., Schaub E., Muriaux D., Cabanne C., Morellet N., Bouaziz S., Darlix J.L., Mely Y., de Rocquigny H. Direct Vpr-Vpr interaction in cells monitored by two photon fluorescence correlation spectroscopy and fluorescence lifetime imaging. Retrovirology 2008, 5:87.
33. Amari K., Boutant E., Hofmann C., Schmitt-Keichinger C., Fernandez-Calvino L., Didier P., Lerich A., Mutterer J., Thomas C.L., Heinlein M., Mély Y., Maule A.J., Ritzenthaler C. A family of plasmodesmal proteins with receptor-like properties for plant viral movement proteins. PLoS Pathog. 2010, 6:e1001119.
34. Sato Y., Ramalanjoana N., Huet T., potier N., Osz J., antony P., Peluso-Iltis C., Ennifar E., Mély Y., Dejaegere A., Moras D., Rochel N. The phantom effect of the rexinoid LG100754: structural and functional insights. PLoS One 2010, 5:e15119.
35. Nakamura Y., Umehara T., Tanaka A., Horikoshi M., Padmanabhan B., Yokoyama S. Structural basis for the recognition between the regulatory particles Nas6 and Rpt3 of the yeast 26S proteasome. Biochem. Biophys. Res. Commun. 2007, 359:503-509.
36. Giovane C., Travé G., Briones A., Wasylyk B., Weiss E. Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric scFvs blocks the E6-mediated degradation of cellular p53. J. Mol. Recogn 1999, 12:141-152.
37. Sibler A.P., Nordhammer A., Masson M., Martineau P., Travé G., Weiss E. Nucleocytoplasmic shuttling of antigen in mammalian cells conferred by a soluble versus insoluble single-chain antibody fragment equipped with import/export signals. Exp. Cell Res. 2003, 286:276-283.
38. Kudo N., Wolff B., Sekimoto T., Schreiner E.P., Yoneda Y., Yanagida M., Horinouchi S., Yoshida M. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 1998, 242:540-547.
39. Chatton B., Bahr A., Acker J., Kedinger C. Eukaryotic GST fusion vector for the study of protein-protein associations in vivo: application to interaction of ATFa with Jun and Fos. Biotechniques 1995, 18:142-145.
40. Esposito A., Dohm C.P., Bähr M., Wouters F.S. Unsupervised fluorescence lifetime imaging microscopy for high content and high throughput screening. Mol. Cell Proteomics 2007, 6:1446-1454.
41. Floor S., van Staveren W., Larsimont D., Dumont J.E., Maenhaut C. Cancer cells in epithelial-tomesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations. Oncogene 2011, 30:4609-4621.
42. Dawson S., Apcher S., Mee M., Higashitsuji H., Baker R., Uhle S., Dubiel W., Fujita J., Mayer R.J. Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26S proteasome. J. Biol. Chem. 2002, 277:10893-10902.
43. Williams B.R., Zhu Z. Intrabody-based approaches to cancer therapy: status and prospects. Curr. Med. Chem. 2006, 13:1473-1480.
44. Böldicke T. Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ER. J. Cell. Mol. Med. 2007, 11:54-70.
45. Lo A.S., Zhu Q., Marasco W.A. Intracellular antibodies (intrabodies) and their therapeutic potential. Handb. Exp. Pharmacol 2008, 181:343-373.
46. Guglielmi L., Denis V., Vezzio-Vié N., Bec N., Dariavach P., Larroque C., Martineau P. Selection for intrabody solubility in mammalian cells using GFP fusions. Protein Eng. Des. Sel. 2011, 24:873-881.
47. Tavoosidana G., Ronquist G., Darmanis S., Yan J., Carlsson L., Wu D., Conze T., Ek P., semjonow A., Eltze E., Larsson A., Landegren U.D., Kamali-Moghaddam M. Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer. Proc. Natl. Acad. Sci U.S.A. 2011, 108:8809-8814.
48. Richards F.F., Konigsberg W.H., Rosenstein R.W., Varga J.M. On the specificity of antibodies. Science 1975, 187:130-137.
49. Van Regenmortel M.H.V. Basic research in HIV vaccinology is hampered by reductionist thinking. Front Immunol. 2012, 3:1-19.
50. Peters J.M., Franke W.W., Kleinschmidt J.A. Distinct 19S and 20S subcomplexes of the 26S proteasome and their distribution in the nucleus and the cytoplasm. J. Biol Chem. 1994, 269:7709-7718.
51. Scharf A., Rockel T.D., von Mikecz A. Localization of proteasomes and proteasomal proteolysis in the mammalian interphase cell nucleus by systematic application of immunocytochemistry. Histochem. Cell Biol. 2007, 127:591-601.
52. Umemura A., Itoh Y., Yamaguchi K., Nakajima T., Higashitsuji H., Ongue H., Fukumoto M., Okanoue T., Fujita J. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma. Hepatology 2008, 47:493-502.
53. Schnell U., Dijk F., Sjollema K.A., Giepmans B.N.G. Immunolabeleling artefacts and the need for live-cell imaging. Nat. Methods 2012, 9:152-157.